Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 study evaluated intranasal esketamine plus an oral antidepressant in elderly patients with treatment-resistant depression; results were completed and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Spravato (esketamine) (esketamine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Treatment-Resistant | Phase 3 | Status: COMPLETED | Results posted: 2019-04-24